2024 annual financial data

Tango Therapeutics 2024 Financial results

Direct answer

Revenue was 42,069,000 USD.

Operating income was -145,595,000 USD and net income was -130,302,000 USD.
Operating cash flow was -131,501,000 USD.

Get free Tango Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
42,069,000 USD
Operating income
-145,595,000 USD
Net income
-130,302,000 USD
Operating cash flow
-131,501,000 USD